| Literature DB >> 34940334 |
Negar Bakhtiary1, Chaozong Liu2, Farnaz Ghorbani3.
Abstract
Nowadays, a prevalent joint disease affecting both cartilage and subchondral bone is osteoarthritis. Osteochondral tissue, a complex tissue unit, exhibited limited self-renewal potential. Furthermore, its gradient properties, including mechanical property, bio-compositions, and cellular behaviors, present a challenge in repairing and regenerating damaged osteochondral tissues. Here, tissue engineering and translational medicine development using bioprinting technology provided a promising strategy for osteochondral tissue repair. In this regard, personalized stratified scaffolds, which play an influential role in osteochondral regeneration, can provide potential treatment options in early-stage osteoarthritis to delay or avoid the use of joint replacements. Accordingly, bioactive scaffolds with possible integration with surrounding tissue and controlling inflammatory responses have promising future tissue engineering perspectives. This minireview focuses on introducing biologically active inks for bioprinting the hierarchical scaffolds, containing growth factors and bioactive materials for 3D printing of regenerative osteochondral substitutes.Entities:
Keywords: bioactive ink; bioprinting; osteochondral; scaffold; tissue engineering
Year: 2021 PMID: 34940334 PMCID: PMC8700778 DOI: 10.3390/gels7040274
Source DB: PubMed Journal: Gels ISSN: 2310-2861
Figure 1Osteochondral defect grades. (A) Normal cartilage (grade 0), (B) Moderate lesion (grade I: partial-thickness defects), (C) Sever lesion (grade III: full-thickness defects), (D) Very sever lesion (grade IV: osteochondral defect) [24,30,31].
Summary of bioactive inks for bone, osteochondral, and cartilage TE.
| Matrix Composition | Properties of Adding Bioactive Component | Tissue Target | 3D Printing Method | Ref. |
|---|---|---|---|---|
| Growth Factor-Containing Inks | ||||
| Alginate-GelMA- TGF-β3 | Promotes ECM Deposition | Cartilage | Extrusion | [ |
| Alginate-BMP-2-VEGF | Improving Angiogenesis or Osteogenesis | Bone | Extrusion | [ |
| DermaMatrix-BMP-2-noggin | Improving Osteogenic Differentiation | Bone | Inkjet | [ |
| Alginate-Gelatin Microparticles-BMP-2 | Improving Osteogenesis and Promoting Bone Regeneration | Bone | Extrusion | [ |
| PCL-Alginate-BMP-2 | Higher GAGs, DNA, and Collagen Content | Cartilage | Extrusion | [ |
| Aptamer-TGF-β3-Decellularize ECM-GelMa-PCL | More Chondrogenic Promoting | Cartilage | Extrusion | [ |
| DNA-Containing Inks | ||||
| Alginate-Methylcellulose -pDNA | Osteogenic and Chondrogenic Differentiation- Bone and Cartilage Formation | Osteochondral | Extrusion | [ |
| Polypeptide-DNA | Cell Viability-Structural Stability | - | Extrusion | [ |
| Alginate-pDNA | Providing Tissue Access to BMP-2 Genes Which Leads to Osteogenic Differentiation | Bone | Extrusion | [ |
| Alginate-Nano HAp-pDNA | Providing Tissue Access to BMP-2 and TGF-β3 Genes Which Leads to Osteogenic Differentiation | Bone | Extrusion | [ |
| ECM-Based Inks | ||||
| Silk-decellularized ECM | Chondrogenic Differentiation | Cartilage | Stereolithography | [ |
| Cartilage decellularized ECM | Better Load Bearing-Chondrogenic Differentiation- Better Printability | Cartilage | Laser | [ |
| PEGDA-decellularized ECM | Chondrogenic Promotion with Subchondral Bone Regeneration | Osteochondral | Stereolithography | [ |
| Alginate-Collagen-ECM | Providing Cell Activities and Promoting Osteogenic Differentiation | Bone | Extrusion | [ |
| Bioactive Polymer-Based Inks | ||||
| Alginate-Collagen | Chondrocyte Phenotype Maintenance and Chondrogenic Promotion | Cartilage | Extrusion | [ |
| Agarose-Collagen | Osteogenic Differentiation | Bone | Inkjet | [ |
| GelMA-HAp | Processability-Good Mechanical properties-Similarity with ECM | Osteochondral | Extrusion | [ |
| Alginate-HA | Promoting Chondrogenesis | Cartilage | Extrusion | [ |
| HA | Chondrogenic Differentiation | Cartilage | FDM | [ |
| PCL-Chitosan | Improving Osteoinductivity | Bone | Extrusion | [ |
| Chitosan-HAp | Influence on Morphology, Viability, Proliferation, and Mineralization | Bone | Extrusion | [ |
| Chitosan-EDTA | Osteogenic differentiation supporting | Bone | Extrusion | [ |
| Alginate | Chondrogenic differentiation by Ca2+ release | Cartilage | Extrusion | [ |
| NFC-Alginate | Stimulating Proteoglycans-Supporting Chondrogenic Differentiation | Cartilage | Inkjet | [ |
| Bioactive Ceramic-Containing Inks | ||||
| Alginate-CPC | Increasing Mineralization and Supporting Subchondral Bone Regeneration | Osteochondral | Extrusion | [ |
| Collagen-TCP | Improving bioactivity-Stimulating Osteogenesis and Increasing Printability | Bone | Extrusion | [ |
| GelMA-Alginate-TCP | Improving Osteogenic and Chondrogenic Differentiation in Addition to Calcified Layer Formation | Osteochondral | Extrusion | [ |
| GelMA-HAp | Positive Effect on Osteoconductivity and Rheological Properties | Bone | Extrusion | [ |
| Gelatin-HAp | Supporting Osteogenic Differentiation | Bone | Extrusion | [ |
| Collagen-HAp | Increase in Osteogenesis-Related Genes Expression | Bone | Extrusion | [ |
| PHBV-45S5 BG | Improving Rheological Properties and Cells Spreading | Bone | FDM | [ |
| Alginate-Chitosan-BG | Osteoenic and Chondrogenic promotion | Osteochondral | Extrusion | [ |
| PLA-BG | Bioactivity, Cytocompatibility, and Osteoinductivity | Bone | FDM | [ |
| Collagen-BG | Osteogenic Differentiation in Addition to Improving Rheological Properties | Bone | Extrusion | [ |
| PCL-BG | HAp-Like Layer Mineralization, ALP Activation, Osteopontin, and Osteocalcin Expression | Bone | FDM | [ |
| Alginate-Gelatin-BG | Higher Mechanical Properties- Higher Cell Viability | Bone | Extrusion | [ |
| Alginate-Sr5(PO4)2SiO4 | Stimulate Chondrocyte Proliferation, Activating the HIF and Wnt Pathways. | Osteochondral | Extrusion | [ |
| GelMA-Nanosilicate | Increasing stiffness-Increasing Enzymatic Stability- Improving Tunable Mechanical Properties-Improving Degradation rate-Supporting Osteogenic Differentiation | Bone | Extrusion | [ |
| Alginate-Graphene Oxide | Antioxidant Activity-Protein Adsorption-ALP Activity-Calcium Deposition-Osteogenic Markers Expression-Printability-Shape fidelity | Bone | Extrusion | [ |
| Alginate-Gelatin-Graphene Oxide | Osteogenic Differentiation and ECM Mineralization | Bone | Extrusion | [ |
| PCL-HAp-MWCNTs | Increasing Mineralization, Proliferation, and Differentiation | Bone | Extrusion | [ |
| PIC-MWCNT | Osteogenic Differentiation and High Bone Mineral Density | Bone | Extrusion | [ |
Figure 2(A). Investigation of impact of scaffolds containing BMP-2, VEGF, and their composition on defect regeneration after 2 weeks. (I) H&E stain with 500 µm and (II) with 100 µm scalebar. (III) Safranin O-stained DB points illustrate that cartilage develops to bone by undergoing endochondral ossification, and (B) points illustrate new bone tissues. (IV) Schematic of 3D-printed experimental groups, including key features of developed bioinks and segmental defect procedure. Construct design (4 mm in diameter, 5 mm in height)(reproduced content is open access) [48]. (B). (I) Representative Live/Dead images with 200 μm scale bar for cell viability and distribution in printed constructs for three layers (top, middle, and bottom) of scaffolds (II) quantification of cell viability, for top, middle, and bottom of printed discs after 0, 3, and 7 days of culture. n ≥ 3, * p < 0.05, ** p < 0.01, n.s. = not significant. (III) CAD design in comparison to representative image of a printed construct for designs of (right) a model femoral condyle and (left) a disc (~1.5 mm thickness, ~6.5 mm diameter). Scale bars = 1 cm (right) and 5 mm (left)(reproduced content is open access) [65].
Figure 3(I) multilayered, 3D-bioprinted scaffold for osteochondral defect. (II) first layer based on alginate ink for articular cartilage regeneration. (III) second layer combination of Alg and CPC for calcified stimulation. (IV) third layer pure CPC for subchondral bone repair. Scale bar illustrates 5mm (reproduced content is open access) [71].
Figure 4(A) Mechanical properties of 3D-printed PLA-45S5 BG scaffolds. (I) designed scaffold using CAD with pore sizes in 750 μm width. (II) Top view image of a PLA-BG scaffold using light microscopy with scale bar = 2 mm. (III) 3D-printed scaffold with FDM method with 0, 1, 2.5, 5, and 10 wt.% BG component (respectively from left to right). Bottom row displays light microscopy images with scale bars = 500 μm. (IV-VII) PLA-BG scaffolds printability and porosity assessment in comparison by Ultimaker PLA filaments as reference depicting (IV) strut diameter, (V) scaffold porosity at side, and (VI) top, as well as (VII) deviation of pore area from theoretical pore area calculated from CAD model as a measure of printing accuracy. (** p < 0.01, **** p < 0.0001 indicate a statistically significant difference of means compared to 3D-printed 0% BG-PLA by one-way ANOVA or Welch’s t-test in pairwise comparisons of scaffold side pore diameter). (B) Immunohistochemistry of MC3T3E1 preosteoblast cells cultured on 3D-printed PLA-BG scaffolds after 24 h. Fluorescence microscopy images display Calcein AM (green) and DAPI (blue) stained cells on PLA-BG scaffolds with BG concentration of (I) 0, (II) 1, (III) 2.5, (IV) 5, and (V) 10 wt.% with 100 μm scale bars sizes and (VI) 10 wt.% with 200 μm scale bar size (reproduced content is open access) [79].
Figure 5(A) Overall photographs and Micro-CT imaging analysis of defects at 8- and 12-weeks postsurgery. (A1–F1) Gross morphology of defects; (A2–F2) 2D projection images of defects; (A3–F3) and (A4–F4) illustrated transverse view and sagittal view of 3D construction images. Off-white color presents primary bone, and white color stands for scaffolds in 2D projection images. Furthermore, off-white color illustrates primary bone, green color illustrates new bone, and red color stands for scaffolds. Compared to that of CTR (blank control) and TCP groups, Micro-CT analysis of defect space exhibited a distinctly greater level of bone regeneration in SPS group (reproduced content is open access) [82]. (B) Light microscopy images of 3D bioprinted cell-laden GO scaffolds cultured in osteogenic media for 1, 7, and 42 days (reproduced content is open access) [85].